In conclusion, the results of the present study suggest that HIV patients at advanced stages (3 or 4) of the disease, when CD4 counts are low and their immune system is compromised, manifest less severe symptoms and less mortality following COVID‐19. The gene discussed is CD4; the disease is COVID-19.